Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.06 USD | -1.94% | -19.30% | +11.95% |
Apr. 16 | Health Care Ticks Up After UnitedHealth Earnings -- Health Care Roundup | DJ |
Apr. 16 | ProPhase Labs, Inc. Unveils Project ZenQ-AI | CI |
Financials (USD)
Sales 2024 * | 54.79M | Sales 2025 * | 138M | Capitalization | 91.31M |
---|---|---|---|---|---|
Net income 2024 * | -14M | Net income 2025 * | 11M | EV / Sales 2024 * | 1.67 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.66 x |
P/E ratio 2024 * |
-6.13
x | P/E ratio 2025 * |
10.5
x | Employees | 113 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.03% |
Latest transcript on ProPhase Labs, Inc.
1 day | -1.94% | ||
1 week | -19.30% | ||
Current month | -21.79% | ||
1 month | -13.36% | ||
3 months | +0.60% | ||
6 months | +12.69% | ||
Current year | +11.95% |
Managers | Title | Age | Since |
---|---|---|---|
Ted Karkus
CEO | Chief Executive Officer | 64 | 09-06-14 |
Chief Operating Officer | 50 | Dec. 31 | |
Robert Morse
AUD | Comptroller/Controller/Auditor | 49 | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Louis Gleckel
BRD | Director/Board Member | 68 | 09-05-31 |
Ted Karkus
CEO | Chief Executive Officer | 64 | 09-06-14 |
Jason Barr
BRD | Director/Board Member | 44 | 15-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 27 M€ | -4.43% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 5.06 | -1.94% | 15,554 |
24-04-23 | 5.16 | +5.31% | 16,630 |
24-04-22 | 4.9 | -6.84% | 62,107 |
24-04-19 | 5.26 | -3.31% | 99,267 |
24-04-18 | 5.44 | -13.24% | 1,176,783 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.95% | 91.31M | |
-16.65% | 8.34B | |
+39.98% | 3.59B | |
-32.00% | 2.75B | |
-7.88% | 2.48B | |
-9.58% | 2.32B | |
-13.29% | 1.79B | |
-19.46% | 1.54B | |
-40.57% | 1.21B | |
+9.70% | 1.13B |
- Stock Market
- Equities
- PRPH Stock